Safety and Efficiency of Method of Exosome Inhalation in COVID-19 Associated Pneumonia

NCT04602442 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Covid19
SARS-CoV-2 PNEUMONIA
COVID-19

Interventions

DRUG: EXO 1 inhalation
DRUG: EXO 2 inhalation
DRUG: Placebo inhalation

Sponsor

Olga Tyumina

Collaborators

[object Object]
[object Object]